Skip to main content

Table 1 Characteristics of the patients in the two treatment groups

From: Efficacy of neural prolotherapy versus local corticosteroid soft tissue injection for treatment of chronic anserine bursitis: a prospective randomized clinical trial

Characteristics of the patient

Group I (NP)

(n = 34 lower limbs obtained from 22 patients)

mean ± SD

Group II (CS)

(n = 33 lower limbs obtained from 21 patients)

mean ± SD

Test of significance

P

Age (year)

41.61 ± 9.28

37.84 ± 9.11

(t) 1.676

0.098

Women†

19 (86.4)

16 (76.2)

(X2) 0.734

0.457§

Weight (kg)

84.73 ± 17.73

81.30 ± 16.73

(t) 0.664

0.418

Height (cm)

163.11 ± 7.05

162.15 ± 5.62

(t) 0.619

0.538

BMI (kg/m2)

31.89 ± 6.72

30.96 ± 6.40

(t) 0.582

0.562

BMI categories

    

 Normal weight†

3 (13.6)

4 (19.0)

(X2) 1.323

0.724

 Overweight†

9 (40.9)

7 (33.4)

  

 Obesity†

6 (27.3)

8 (38.1)

  

 Morbid obesity†

4 (18.2)

2 (9.5)

  

Duration of the symptoms (months)

7.44 ± 4.34

8.39 ± 4.86

(t) − 0.847

0.400

Bilaterally†

12 (54.5)

12 (57.1)

(X2) 0.029

0.864

Side (right/left)‡

19/15 (55.9/44.1)

16/17 (48.5/51.5)

(X2) 0.367

0.628

  1. kg kilogram, cm centimeter, m meter, BMI body mass index, NP neural prolotherapy group, n number, SD standard deviation, CS corticosteroid group, t value of Student’s t-test, X2 value of Chi-square test
  2. *P is significant at < 0.05
  3. †Data are represented as number (percentage) of participants
  4. ‡Data are represented as number (percentage) of lower limbs
  5. §P value of Fisher’s exact test